Welcome to Our Medtech Talk Podcast Channel

Too often we define the Medtech sector by the number of dollars raised, IPOs helped or companies sold. But the focus neglects the very foundation of the sector - the People. Join the Medtech Talk Podcast each week to hear from entrepreneurs, investors and executives who spend their days developing the tools that make sick people well and health care more efficient.

Pixium CEO Sees Great Promise for PRIMA Implant

February 6, 2018

Khalid Ishaque says Bioelectronic Medicine has made great strides in treating hearing loss, depression, and other maladies and shows great promise in treating neurological disorders like Alzheimer’s disease. Yet, most people still see it as more science fiction than science fact. But that’s changing. “What we are demonstrating with advances in miniaturization, imaging, and increased understanding of the cellular pathways and the brain is that what was once considered impossible is becoming possible,” he declares. Overview: Pixium Vision is making great progress with its PRIMA subretinal implant. Surprises: I thought the study was limited to Europe, but the company will be enrolling patients in Pittsburgh too. Regrets: I wish I were running a “TransHuman: Innovation Summit”. Listen at the end of the podcast. Enjoy the podcast!

Khalid Ishaque

CEO

PIXIUM VISION

Khalid Ishaque has over 20 years of experience in the medical technology sector. He joined Pixium Vision in 2014 after having spent 17 years with the Boston Scientific in various commercial and business development roles, and most recently as General Manager of International Neuromodulation division commercialising Spinal Cord and Deep Brain Stimulation systems for chronic pain and movement disorders. Before joining Boston Scientific in 1997, he worked for Becton Dickinson. He received his Master in engineering from Cranfield Institute of Technology in the United Kingdom and Master in international Economics and Management from SDA Bocconi University in Italy.